SEP 07, 2020 8:16 PM PDT

Improving Antirejection Medications in Heart Transplant

WRITTEN BY: Nouran Amin

Placing patients on anti-rejection drugs is reality for all heart transplant patients. As such, recent research at Johns Hopkins Medicine and the National Cancer Institute (NCI) treated mice with a promising anti-rejection drug delivered to the area surrounding a grafted heart. The drug was packaged in a tiny three-dimensional, protein gel cocoon known as a hydrogel. The therapeutic was then released in mice over time—providing regulation in eliminating the need for daily mediation in human patients.

"What was needed was a drug delivery method that would get the anti-rejection medication only where needed; protect the drug from premature degradation; and maintain a high concentration for the period of time needed to retrain the immune system," says study co-author Giorgio Raimondi, M.Sc., Ph.D., assistant professor of plastic and reconstructive surgery at the Johns Hopkins University School of Medicine.

Findings were published in the journal Small.

"Two earlier studies used the hydrogel method to successfully deliver conventional immunosuppressive drugs to other sites, and this prompted us to try it out for transplanted hearts," Raimondi explains.

Learn more about anti-rejection medication in transplantation:

"Additionally, work by a team at the NCI Frederick National Laboratory for Cancer Research under Joel Schneider [Ph.D., a study co-author] showed that hydrogel-drug packages can be administered by syringe."

Source: Science Daily

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
AUG 16, 2020
Neuroscience
Study Says Social Connection Best Way to Prevent Depression
AUG 16, 2020
Study Says Social Connection Best Way to Prevent Depression
Depression is the world's leading source of disability. Now, researchers from Massachusetts General Hospital (MGH) h ...
AUG 06, 2020
Drug Discovery & Development
How Medieval Medicine Can Conquer Modern Day Infections?
AUG 06, 2020
How Medieval Medicine Can Conquer Modern Day Infections?
One of our current global threats is antibiotic resistance.     As more biofilm-associated infections are ...
AUG 25, 2020
Drug Discovery & Development
Drug Combination Reduces Cardiovascular Complications
AUG 25, 2020
Drug Combination Reduces Cardiovascular Complications
According to a new study, combining the drugs hydroxychloroquine (HCQ) and azithromycin (AZM) was shown to reduce cardio ...
AUG 17, 2020
Drug Discovery & Development
How Do Drugs Treat Parasitic Infections?
AUG 17, 2020
How Do Drugs Treat Parasitic Infections?
How Do Medications Deal With Parasitic Infections? Researchers have been curious to know how a common medication battles ...
SEP 15, 2020
Drug Discovery & Development
How Can Genetic Data Make Informed Decisions About Drug Development?
SEP 15, 2020
How Can Genetic Data Make Informed Decisions About Drug Development?
How Can Genetic Data Make Informed Decisions About Drug Development? Scientists at the Integrative Epidemiology Unit (MR ...
OCT 01, 2020
Cancer
Understanding in vivo Metabolomics: C13 Isotope Studies
OCT 01, 2020
Understanding in vivo Metabolomics: C13 Isotope Studies
One key to understanding cancer metabolomics lies in the ability to accurately replicate the natural environment of the ...
Loading Comments...